• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Anette Breindl

Articles by Anette Breindl

New approach makes immune cells kiss and tell

March 20, 2019
By Anette Breindl
Long before any currently available detection method can find a tumor, the future patient's immune cells have found that tumor and are working on eliminating it. Now, researchers from Stanford University have developed a method to use such immune cells as sentinels, enabling earlier detection of tumors.
Read More

Knocking out innate immune protein decreases gut GVHD

March 18, 2019
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

March 18, 2019
By Anette Breindl
There are a number of so-called undruggable targets that have eluded attempts to find potent small-molecule compounds to affect their expression. One such protein is the oncogenic transcription factor Myc. Now, scientists from McGill University have developed a screen that could detect compounds that indirectly affect Myc expression. 
Read More

Knocking out innate immune protein decreases gut GVHD

March 15, 2019
By Anette Breindl
The innate immune protein NLRP6, which plays a protective role in inflammatory bowel disease (IBD), appears to aggravate intestinal graft-vs.-host disease (GVHD).
Read More

For HIV medications, less is more, even if it means injections

March 13, 2019
By Anette Breindl
SEATTLE – Clinical trial data for both approved and experimental HIV drugs were presented on the last day of the Conference on Retroviruses and Opportunistic Infections (CROI).
Read More

For HIV medications, less is more, even if it means injections

March 11, 2019
By Anette Breindl
SEATTLE – Clinical trial data for both approved and experimental HIV drugs were presented on the last day of the Conference on Retroviruses and Opportunistic Infections (CROI).
Read More

Bench Press: BioWorld looks at translational medicine

March 11, 2019
By Anette Breindl
Stimulator of interferon genes (STING) is an innate immune protein whose function is well described by its name. However, researchers at the University of Texas Southwestern Medical Center have discovered that STING also has a role in activating autophagy. 
Read More

At CROI, learning from rebounds

March 8, 2019
By Anette Breindl
SEATTLE – The general public and HIV researchers alike were excited by the report out of the Conference on Retroviruses and Opportunistic Infections (CROI) this week that a second patient, the London patient, has been in long-term remission from HIV after receiving a bone marrow transplant with HIV-resistant cells to treat cancer.
Read More

NIAID's Fauci says ending AIDS epidemic in U.S. is realistic goal

March 6, 2019
By Anette Breindl
SEATTLE –To hear National Institute of Allergy and Infectious Diseases Director Anthony Fauci tell it, ending the AIDS epidemic in the U.S. is another one of those things that took 20 years to become an overnight sensation.
Read More

Excitement about London patient, but road to generality still unclear

March 6, 2019
By Anette Breindl
SEATTLE – Ten years after "Berlin patient" Timothy Ray Brown, a second patient has achieved long-term undetectable viral load in the absence of antiretroviral treatment (ART) after receiving a bone marrow transplant with hematopoietic stem cells with a nonfunctional version of the CCR5 receptor, a surface molecule on helper T cells that is used as an entry co-receptor by HIV.
Read More
Previous 1 2 … 106 107 108 109 110 111 112 113 114 … 392 393 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 28, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 27, 2025.
  • Biotech deal illustration

    City hits the town with $1B-plus deal with Biogen

    BioWorld
    A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. It’s a step in the direction the company...
  • Salvia Bioelectronics MySalvia implant

    Salvia raises $60M for neuromodulation migraine system

    BioWorld MedTech
    Salvia Bioelectronics BV raised $60 million in a series B financing round for its minimally invasive implantable neuromodulation device, Mysalvia therapy, which...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe